{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:51:38Z","timestamp":1792612298832,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 2022-0763"],"award-info":[{"award-number":["PIP 2022-0763"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Ministry of Science, Technology and Productive Innovation, Argentina | Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2017-2431 and PICT 2021-I-A-00716"],"award-info":[{"award-number":["PICT 2017-2431 and PICT 2021-I-A-00716"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Ministry of Science, Technology and Productive Innovation, Argentina | Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2018-03070 and PICT-2021-I-A-00807"],"award-info":[{"award-number":["PICT 2018-03070 and PICT-2021-I-A-00807"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41380-025-03338-w","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:59:41Z","timestamp":1763463581000},"page":"1970-1982","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ketamine reduces microglial activation and brain monocyte infiltration and promotes peripheral regulatory immune cells, relieving lipopolysaccharide (LPS)-induced depressive-like behavior in mice"],"prefix":"10.1038","volume":"31","author":[{"given":"Angeles Romina","family":"Arena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2513-5975","authenticated-orcid":false,"given":"Mara Roxana","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Genaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Tifner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Mariel","family":"Risnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhon Esteban","family":"L\u00f3pez-Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2949-7252","authenticated-orcid":false,"given":"Federico Manuel","family":"Daray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4428-8213","authenticated-orcid":false,"given":"Eugenio Antonio","family":"Carrera Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2384-775X","authenticated-orcid":false,"given":"Andrea Emilse","family":"Errasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"3338_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"Collaborators GBDMD","year":"2022","unstructured":"Collaborators GBDMD. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137\u201350.","journal-title":"Lancet Psychiatry"},{"key":"3338_CR2","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","volume":"60","author":"BN Gaynes","year":"2009","unstructured":"Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M, Rush AJ. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv. 2009;60:1439\u201345.","journal-title":"Psychiatr Serv"},{"key":"3338_CR3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391:1357\u201366.","journal-title":"Lancet"},{"key":"3338_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s43440-021-00232-4","volume":"73","author":"S Kohtala","year":"2021","unstructured":"Kohtala S. Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms. Pharmacol Rep. 2021;73:323\u201345.","journal-title":"Pharmacol Rep"},{"key":"3338_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41386-023-01629-w","volume":"49","author":"JH Krystal","year":"2024","unstructured":"Krystal JH, Kavalali ET, Monteggia LM. Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms. Neuropsychopharmacology. 2024;49:41\u201350.","journal-title":"Neuropsychopharmacology"},{"key":"3338_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-med-051322-120608","volume":"75","author":"JW Kim","year":"2024","unstructured":"Kim JW, Suzuki K, Kavalali ET, Monteggia LM. Ketamine: mechanisms and relevance to treatment of depression. Annu Rev Med. 2024;75:129\u201343.","journal-title":"Annu Rev Med"},{"key":"3338_CR7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/mp.2017.255","volume":"23","author":"P Zanos","year":"2018","unstructured":"Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Mol psychiatry. 2018;23:801\u201311.","journal-title":"Mol psychiatry"},{"key":"3338_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320916657","volume":"10","author":"D Matveychuk","year":"2020","unstructured":"Matveychuk D, Thomas RK, Swainson J, Khullar A, MacKay MA, Baker GB, et al. Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers. Ther Adv Psychopharmacol. 2020;10:2045125320916657.","journal-title":"Ther Adv Psychopharmacol"},{"key":"3338_CR9","unstructured":"Hashimoto K The NMDA Receptors The Receptors, 1st edn. Springer International Publishing : Imprint: Humana,: Cham, 2017. p. 1 online resource (X, 148 pages 122 illustrations, 114 illustrations in color."},{"key":"3338_CR10","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1523\/JNEUROSCI.1316-22.2022","volume":"43","author":"P Zanos","year":"2023","unstructured":"Zanos P, Brown KA, Georgiou P, Yuan P, Zarate CA Jr., Thompson SM, et al. NMDA receptor activation-dependent antidepressant-relevant behavioral and synaptic actions of ketamine. J Neurosci. 2023;43:1038\u201350.","journal-title":"J Neurosci"},{"key":"3338_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2021.100383","volume":"18","author":"N Nikkheslat","year":"2021","unstructured":"Nikkheslat N. Targeting inflammation in depression: ketamine as an anti-inflammatory antidepressant in psychiatric emergency. Brain Behav Immun Health. 2021;18:100383.","journal-title":"Brain Behav Immun Health"},{"key":"3338_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1124\/jpet.123.001823","volume":"388","author":"M Jozwiak-Bebenista","year":"2024","unstructured":"Jozwiak-Bebenista M, Sokolowska P, Wiktorowska-Owczarek A, Kowalczyk E, Sienkiewicz M. Ketamine - a new antidepressant drug with anti-inflammatory properties. J pharmacology Exp therapeutics. 2024;388:134\u201344.","journal-title":"J pharmacology Exp therapeutics"},{"key":"3338_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1515\/tnsci-2020-0167","volume":"12","author":"N Zhang","year":"2021","unstructured":"Zhang N, Yao L, Wang P, Liu Z. Immunoregulation and antidepressant effect of ketamine. Transl Neurosci. 2021;12:218\u201336.","journal-title":"Transl Neurosci"},{"key":"3338_CR14","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1213\/ANE.0b013e3182662e30","volume":"115","author":"O Dale","year":"2012","unstructured":"Dale O, Somogyi AA, Li Y, Sullivan T, Shavit Y. Does intraoperative ketamine attenuate inflammatory reactivity following surgery? a systematic review and meta-analysis. Anesth Analg. 2012;115:934\u201343.","journal-title":"Anesth Analg"},{"key":"3338_CR15","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.biopsych.2014.06.021","volume":"77","author":"JJ Yang","year":"2015","unstructured":"Yang JJ, Wang N, Yang C, Shi JY, Yu HY, Hashimoto K. Serum interleukin-6 is a predictive biomarker for ketamine\u2019s antidepressant effect in treatment-resistant patients with major depression. Biol psychiatry. 2015;77:e19\u2013e20.","journal-title":"Biol psychiatry"},{"key":"3338_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.psychres.2018.08.078","volume":"269","author":"MH Chen","year":"2018","unstructured":"Chen MH, Li CT, Lin WC, Hong CJ, Tu PC, Bai YM, et al. Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study. Psychiatry Res. 2018;269:207\u201311.","journal-title":"Psychiatry Res"},{"key":"3338_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-00933-z","volume":"10","author":"Y Zhan","year":"2020","unstructured":"Zhan Y, Zhou Y, Zheng W, Liu W, Wang C, Lan X, et al. Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder. Transl psychiatry. 2020;10:246.","journal-title":"Transl psychiatry"},{"key":"3338_CR18","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ebiom.2019.10.063","volume":"50","author":"W Nowak","year":"2019","unstructured":"Nowak W, Grendas LN, Sanmarco LM, Estecho IG, Arena AR, Eberhardt N, et al. Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR. EBioMedicine. 2019;50:290\u2013305.","journal-title":"EBioMedicine"},{"key":"3338_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","volume":"35","author":"RS Smith","year":"1991","unstructured":"Smith RS. The macrophage theory of depression. Med hypotheses. 1991;35:298\u2013306.","journal-title":"Med hypotheses"},{"key":"3338_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.iac.2009.02.002","volume":"29","author":"R Dantzer","year":"2009","unstructured":"Dantzer R. Cytokine, sickness behavior, and depression. Immunology allergy Clin North Am. 2009;29:247\u201364.","journal-title":"Immunology allergy Clin North Am"},{"key":"3338_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","volume":"135","author":"CA Kohler","year":"2017","unstructured":"Kohler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta psychiatr Scand. 2017;135:373\u201387.","journal-title":"Acta psychiatr Scand"},{"key":"3338_CR22","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41380-018-0096-3","volume":"25","author":"JC Felger","year":"2020","unstructured":"Felger JC, Haroon E, Patel TA, Goldsmith DR, Wommack EC, Woolwine BJ, et al. What does plasma CRP tell us about peripheral and central inflammation in depression? Mol psychiatry. 2020;25:1301\u201311.","journal-title":"Mol psychiatry"},{"key":"3338_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12974-023-02757-2","volume":"20","author":"NV Sorensen","year":"2023","unstructured":"Sorensen NV, Borbye-Lorenzen N, Christensen RHB, Orlovska-Waast S, Jeppesen R, Skogstrand K, et al. Comparisons of 25 cerebrospinal fluid cytokines in a case-control study of 106 patients with recent-onset depression and 106 individually matched healthy subjects. J neuroinflamm. 2023;20:90.","journal-title":"J neuroinflamm"},{"key":"3338_CR24","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1038\/s41380-024-02587-5","volume":"29","author":"FM Daray","year":"2024","unstructured":"Daray FM, Chiapella LC, Grendas LN, Casiani RIA, Olaviaga A, Robetto J, et al. Peripheral blood cellular immunophenotype in suicidal ideation, suicide attempt, and suicide: a systematic review and meta-analysis. Mol psychiatry. 2024;29:3874\u201392.","journal-title":"Mol psychiatry"},{"key":"3338_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2024.100777","volume":"38","author":"LN Grendas","year":"2024","unstructured":"Grendas LN, Carrera Silva EA, Alvarez Casiani RI, Olaviaga A, Robetto J, Arena AR, et al. Immunological alterations in patients with current and lifetime suicide ideation and attempts: Examining the relationship with depressive symptoms. Brain Behav Immun Health. 2024;38:100777.","journal-title":"Brain Behav Immun Health"},{"key":"3338_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02902-2","volume":"14","author":"FM Daray","year":"2024","unstructured":"Daray FM, Grendas LN, Arena AR, Tifner V, Alvarez Casiani RI, Olaviaga A, et al. Decoding the inflammatory signature of the major depressive episode: insights from peripheral immunophenotyping in active and remitted condition, a case-control study. Transl psychiatry. 2024;14:254.","journal-title":"Transl psychiatry"},{"key":"3338_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neubiorev.2020.05.001","volume":"115","author":"J Lasselin","year":"2020","unstructured":"Lasselin J, Schedlowski M, Karshikoff B, Engler H, Lekander M, Konsman JP. Comparison of bacterial lipopolysaccharide-induced sickness behavior in rodents and humans: relevance for symptoms of anxiety and depression. Neurosci Biobehav Rev. 2020;115:15\u201324.","journal-title":"Neurosci Biobehav Rev"},{"key":"3338_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1181973","volume":"14","author":"R Yin","year":"2023","unstructured":"Yin R, Zhang K, Li Y, Tang Z, Zheng R, Ma Y, et al. Lipopolysaccharide-induced depression-like model in mice: meta-analysis and systematic evaluation. Front immunol. 2023;14:1181973.","journal-title":"Front immunol"},{"key":"3338_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2021.759574","volume":"15","author":"A Eltokhi","year":"2021","unstructured":"Eltokhi A, Kurpiers B, Pitzer C. Baseline depression-like behaviors in wild-type adolescent mice are strain and age but not sex dependent. Front Behav Neurosci. 2021;15:759574.","journal-title":"Front Behav Neurosci"},{"key":"3338_CR30","doi-asserted-by":"publisher","unstructured":"Can A, Dao DT, Terrillion CE, Piantadosi SC, Bhat S, Gould TD The tail suspension test. J visualized Exp 2012;e3769. https:\/\/doi.org\/10.3791\/3769.","DOI":"10.3791\/3769"},{"key":"3338_CR31","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/2041-210X.12584","volume":"7","author":"O Friard","year":"2016","unstructured":"Friard O, Gamba M. BORIS: a free, versatile open\u2010source event\u2010logging software for video\/audio coding and live observations. Methods Ecol evolution. 2016;7:1325\u201330.","journal-title":"Methods Ecol evolution"},{"key":"3338_CR32","doi-asserted-by":"publisher","first-page":"e3056","DOI":"10.21769\/BioProtoc.3056","volume":"8","author":"AF Leblanc","year":"2018","unstructured":"Leblanc AF, Huang KM, Uddin ME, Anderson JT, Chen M, Hu S. Murine pharmacokinetic studies. Bio-protocol. 2018;8:e3056.","journal-title":"Bio-protocol"},{"key":"3338_CR33","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3389\/fimmu.2017.01666","volume":"8","author":"JM Peralta Ramos","year":"2017","unstructured":"Peralta Ramos JM, Bussi C, Gaviglio EA, Arroyo DS, Baez NS, Rodriguez-Galan MC, et al. Type I IFNs are required to promote central nervous system immune surveillance through the recruitment of inflammatory monocytes upon systemic inflammation. Front immunol. 2017;8:1666.","journal-title":"Front immunol"},{"key":"3338_CR34","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/10253890.2021.1978425","volume":"24","author":"S Quiroga","year":"2021","unstructured":"Quiroga S, Juarez YR, Marcone MP, Vidal MA, Genaro AM, Burgueno AL. Prenatal stress promotes insulin resistance without inflammation or obesity in C57BL\/6J male mice. Stress. 2021;24:987\u201397.","journal-title":"Stress"},{"key":"3338_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2022.105416","volume":"160","author":"A Prochnik","year":"2022","unstructured":"Prochnik A, Burgueno AL, Rubinstein MR, Marcone MP, Bianchi MS, Gonzalez Murano MR, et al. Sexual dimorphism modulates metabolic and cognitive alterations under HFD nutrition and chronic stress exposure in mice. Correlation between spatial memory impairment and BDNF mRNA expression in hippocampus and spleen. Neurochem Int. 2022;160:105416.","journal-title":"Neurochem Int"},{"key":"3338_CR36","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3389\/fimmu.2018.01341","volume":"9","author":"ME Di Rosso","year":"2018","unstructured":"Di Rosso ME, Sterle HA, Cremaschi GA, Genaro AM. Beneficial effect of fluoxetine and sertraline on chronic stress-induced tumor growth and cell dissemination in a mouse model of lymphoma: crucial role of antitumor immunity. Front immunol. 2018;9:1341.","journal-title":"Front immunol"},{"key":"3338_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/1547691X.2013.800171","volume":"11","author":"CG Pascuan","year":"2014","unstructured":"Pascuan CG, Uran SL, Gonzalez-Murano MR, Wald MR, Guelman LR, Genaro AM. Immune alterations induced by chronic noise exposure: comparison with restraint stress in BALB\/c and C57Bl\/6 mice. J Immunotoxicol. 2014;11:78\u201383.","journal-title":"J Immunotoxicol"},{"key":"3338_CR38","doi-asserted-by":"publisher","unstructured":"Mildner A, Marinkovic G, Jung S. Murine Monocytes: Origins, Subsets, Fates, and Functions. Microbiol Spectr. 2016;4. https:\/\/doi.org\/10.1128\/microbiolspec.MCHD-0033-2016.","DOI":"10.1128\/microbiolspec.MCHD-0033-2016"},{"key":"3338_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1475435","volume":"2016","author":"S Sprangers","year":"2016","unstructured":"Sprangers S, de Vries TJ, Everts V. Monocyte heterogeneity: consequences for monocyte-derived immune cells. J Immunol Res. 2016;2016:1475435.","journal-title":"J Immunol Res"},{"key":"3338_CR40","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.immuni.2018.10.005","volume":"49","author":"M Guilliams","year":"2018","unstructured":"Guilliams M, Mildner A, Yona S. Developmental and functional heterogeneity of monocytes. Immunity. 2018;49:595\u2013613.","journal-title":"Immunity"},{"key":"3338_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4049\/jimmunol.182.1.111","volume":"182","author":"Y Han","year":"2009","unstructured":"Han Y, Guo Q, Zhang M, Chen Z, Cao X. CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1. J Immunol. 2009;182:111\u201320.","journal-title":"J Immunol"},{"key":"3338_CR42","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.4049\/jimmunol.1100765","volume":"188","author":"K Radulovic","year":"2012","unstructured":"Radulovic K, Manta C, Rossini V, Holzmann K, Kestler HA, Wegenka UM, et al. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential. J Immunol. 2012;188:2001\u201313.","journal-title":"J Immunol"},{"key":"3338_CR43","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","volume":"44","author":"AC Anderson","year":"2016","unstructured":"Anderson AC, Joller N, Kuchroo VK. Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation. Immunity. 2016;44:989\u20131004.","journal-title":"Immunity"},{"key":"3338_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0927-9","volume":"9","author":"L Yu","year":"2018","unstructured":"Yu L, Yang F, Zhang F, Guo D, Li L, Wang X, et al. CD69 enhances immunosuppressive function of regulatory T-cells and attenuates colitis by prompting IL-10 production. Cell death Dis. 2018;9:905.","journal-title":"Cell death Dis"},{"key":"3338_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","volume":"163","author":"CA Zarate Jr.","year":"2006","unstructured":"Zarate CA Jr., Singh JB, Quiroz JA, De Jesus G, Denicoff KK, Luckenbaugh DA, et al. A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J psychiatry. 2006;163:153\u20135.","journal-title":"Am J psychiatry"},{"key":"3338_CR46","doi-asserted-by":"publisher","first-page":"8649","DOI":"10.1073\/pnas.1323920111","volume":"111","author":"ES Gideons","year":"2014","unstructured":"Gideons ES, Kavalali ET, Monteggia LM. Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses. Proc Natl Acad Sci USA. 2014;111:8649\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3338_CR47","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","volume":"175","author":"NR Williams","year":"2018","unstructured":"Williams NR, Heifets BD, Blasey C, Sudheimer K, Pannu J, Pankow H, et al. Attenuation of antidepressant effects of ketamine by opioid receptor antagonism. Am J psychiatry. 2018;175:1205\u201315.","journal-title":"Am J psychiatry"},{"key":"3338_CR48","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/cpt.3478","volume":"117","author":"KA Vekhova","year":"2025","unstructured":"Vekhova KA, Namiot ED, Jonsson J, Schioth HB. Ketamine and esketamine in clinical trials: FDA-approved and emerging indications, trial trends with putative mechanistic explanations. Clin Pharmacol Ther. 2025;117:374\u201386.","journal-title":"Clin Pharmacol Ther"},{"key":"3338_CR49","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.3390\/biomedicines12102283","volume":"12","author":"P Kawczak","year":"2024","unstructured":"Kawczak P, Feszak I, Baczek T. Ketamine, esketamine, and arketamine: their mechanisms of action and applications in the treatment of depression and alleviation of depressive symptoms. Biomedicines. 2024;12:2283.","journal-title":"Biomedicines"},{"key":"3338_CR50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","volume":"139","author":"Y Liu","year":"2012","unstructured":"Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. 2012;139:230\u20139.","journal-title":"J Affect Disord"},{"key":"3338_CR51","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jad.2020.09.025","volume":"277","author":"M Colasanto","year":"2020","unstructured":"Colasanto M, Madigan S, Korczak DJ. Depression and inflammation among children and adolescents: a meta-analysis. J Affect Disord. 2020;277:940\u20138.","journal-title":"J Affect Disord"},{"key":"3338_CR52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/mp.2017.205","volume":"23","author":"SP Leighton","year":"2018","unstructured":"Leighton SP, Nerurkar L, Krishnadas R, Johnman C, Graham GJ, Cavanagh J. Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis. Mol psychiatry. 2018;23:48\u201358.","journal-title":"Mol psychiatry"},{"key":"3338_CR53","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biopsych.2019.11.017","volume":"88","author":"ME Lynall","year":"2020","unstructured":"Lynall ME, Turner L, Bhatti J, Cavanagh J, de Boer P, Mondelli V, et al. Peripheral blood cell-stratified subgroups of inflamed depression. Biol psychiatry. 2020;88:185\u201396.","journal-title":"Biol psychiatry"},{"key":"3338_CR54","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","volume":"107","author":"E Beurel","year":"2020","unstructured":"Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107:234\u201356.","journal-title":"Neuron"},{"key":"3338_CR55","doi-asserted-by":"publisher","first-page":"eaav0492","DOI":"10.1126\/sciimmunol.aav0492","volume":"4","author":"P Mastorakos","year":"2019","unstructured":"Mastorakos P, McGavern D. The anatomy and immunology of vasculature in the central nervous system. Sci immunol. 2019;4:eaav0492.","journal-title":"Sci immunol"},{"key":"3338_CR56","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22\u201334.","journal-title":"Nat Rev Immunol"},{"key":"3338_CR57","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.immuni.2025.04.006","volume":"58","author":"J Bastos","year":"2025","unstructured":"Bastos J, O\u2019Brien C, Vara-Perez M, Mampay M, van Olst L, Barry-Carroll L, et al. Monocytes can efficiently replace all brain macrophages and fetal liver monocytes can generate bona fide SALL1(+) microglia. Immunity. 2025;58:1269\u201388 e1212.","journal-title":"Immunity"},{"key":"3338_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2025.103563","volume":"392","author":"V Tifner","year":"2025","unstructured":"Tifner V, Daray FM, Lopez-Carvajal JE, Arena AR, Grendas LN, Alvarez Casiani RI, et al. Unbalanced CD4(+)IL-10(+) and more activated and exhausted CD8(+) lymphocytes characterized patients with a major depressive episode. J pharmacol Exp ther. 2025;392:103563.","journal-title":"J pharmacol Exp ther"},{"key":"3338_CR59","doi-asserted-by":"publisher","first-page":"16136","DOI":"10.1073\/pnas.1415191111","volume":"111","author":"GE Hodes","year":"2014","unstructured":"Hodes GE, Pfau ML, Leboeuf M, Golden SA, Christoffel DJ, Bregman D, et al. Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc Natl Acad Sci USA. 2014;111:16136\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3338_CR60","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.3390\/biomedicines10081929","volume":"10","author":"IB Kim","year":"2022","unstructured":"Kim IB, Lee JH, Park SC. The relationship between stress, inflammation, and depression. Biomedicines. 2022;10:1929.","journal-title":"Biomedicines"},{"key":"3338_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1130989","volume":"14","author":"S Hassamal","year":"2023","unstructured":"Hassamal S. Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories. Front psychiatry. 2023;14:1130989.","journal-title":"Front psychiatry"},{"key":"3338_CR62","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002130100694","volume":"155","author":"I Lucki","year":"2001","unstructured":"Lucki I, Dalvi A, Mayorga AJ. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology. 2001;155:315\u201322.","journal-title":"Psychopharmacology"},{"key":"3338_CR63","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 2010;329:959\u201364.","journal-title":"Science"},{"key":"3338_CR64","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/mp.2011.47","volume":"16","author":"E Beurel","year":"2011","unstructured":"Beurel E, Song L, Jope RS. Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol psychiatry. 2011;16:1068\u201370.","journal-title":"Mol psychiatry"},{"key":"3338_CR65","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1007\/s00213-015-4062-3","volume":"232","author":"JC Zhang","year":"2015","unstructured":"Zhang JC, Yao W, Dong C, Yang C, Ren Q, Ma M, et al. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression. Psychopharmacology. 2015;232:4325\u201335.","journal-title":"Psychopharmacology"},{"key":"3338_CR66","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature. 2016;533:481\u20136.","journal-title":"Nature"},{"key":"3338_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29686","volume":"10","author":"SP Dash","year":"2024","unstructured":"Dash SP, Gupta S, Sarangi PP. Monocytes and macrophages: origin, homing, differentiation, and functionality during inflammation. Heliyon. 2024;10:e29686.","journal-title":"Heliyon"},{"key":"3338_CR68","doi-asserted-by":"publisher","first-page":"14971","DOI":"10.1074\/jbc.M600236200","volume":"281","author":"A Roy","year":"2006","unstructured":"Roy A, Fung YK, Liu X, Pahan K. Up-regulation of microglial CD11b expression by nitric oxide. J Biol Chem. 2006;281:14971\u201380.","journal-title":"J Biol Chem"},{"key":"3338_CR69","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fncel.2020.00198","volume":"14","author":"AM Jurga","year":"2020","unstructured":"Jurga AM, Paleczna M, Kuter KZ. Overview of general and discriminating markers of differential microglia phenotypes. Front Cell Neurosci. 2020;14:198.","journal-title":"Front Cell Neurosci"},{"key":"3338_CR70","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.autrev.2018.02.001","volume":"17","author":"D Brandt","year":"2018","unstructured":"Brandt D, Hedrich CM. TCRalphabeta(+)CD3(+)CD4(-)CD8(-) (double negative) T cells in autoimmunity. Autoimmun Rev. 2018;17:422\u201330.","journal-title":"Autoimmun Rev"},{"key":"3338_CR71","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/BOR.0000000000000778","volume":"33","author":"H Li","year":"2021","unstructured":"Li H, Tsokos GC. Double-negative T cells in autoimmune diseases. Curr Opin Rheumatol. 2021;33:163\u201372.","journal-title":"Curr Opin Rheumatol"},{"key":"3338_CR72","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/imm.13441","volume":"165","author":"T Velikkakam","year":"2022","unstructured":"Velikkakam T, Gollob KJ, Dutra WO. Double-negative T cells: Setting the stage for disease control or progression. Immunology. 2022;165:371\u201385.","journal-title":"Immunology"},{"key":"3338_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202416481","volume":"12","author":"C Lin","year":"2025","unstructured":"Lin C, Zhou X, Li M, Zhang C, Zhai H, Li H, et al. S-ketamine alleviates neuroinflammation and attenuates lipopolysaccharide-induced depression via targeting SIRT2. Adv Sci. 2025;12:e2416481.","journal-title":"Adv Sci"},{"key":"3338_CR74","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","volume":"25","author":"M Fava","year":"2020","unstructured":"Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, et al. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Mol psychiatry. 2020;25:1592\u2013603.","journal-title":"Mol psychiatry"},{"key":"3338_CR75","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuron.2019.02.005","volume":"101","author":"JH Krystal","year":"2019","unstructured":"Krystal JH, Abdallah CG, Sanacora G, Charney DS, Duman RS. Ketamine: a paradigm shift for depression research and treatment. Neuron. 2019;101:774\u20138.","journal-title":"Neuron"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03338-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03338-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03338-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:02:58Z","timestamp":1773824578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03338-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["3338"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-03338-w","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal protocol was approved by the Institutional Animal Care and Use Committee (CICUAL BIOMED N\u00b001\/2022). The use of experimental animals complied with the National Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}